MRP ₹212.00
Inclusive of all taxes
Get this at ₹173.84
Cart Total
₹0
*10 Tablet(s) in a Strip * Mkt: Fourrts India Laboratories Pvt Ltd * Country of Origin: India * Delivery charges if applicable will be applied at checkout

Availability & Expiry
Delivering To

INTRODUCTION

REJUNURON DN TABLET is a combination of Pregabalin and Methylcobalamin which belongs to the group of medicines called Anticonvulsants and Vitamin-B complex respectively. REJUNURON DN TABLET is indicated for the treatment of neuropathic pain in adults. Neuropathic pain is a chronic painful condition caused by damage or disease affecting the somatosensory (sense of touch) nervous system (such as lesion or disease of spinal cord and/or brain).

It can also be caused by prolonged diabetes mellitus, infectious diseases (such as HIV infection or leprosy), chemotherapy, auto-immune disease (Ex. Guillain-Barre syndrome) or by other metabolic dysfunctions. Symptoms include shooting, burning or stabbing pain, tingling and numbness, spontaneous pain (pain without stimulus) or pain caused by normal daily activities that are typically not painful (such as brushing your hair, being in cold temperatures or rubbing against something).

Do not stop taking REJUNURON DN TABLET without consulting your doctor as it could precipitate withdrawal symptoms such as headache, insomnia (lack of sleep), nausea, pain, diarrhea, flu syndrome, anxiety, nervousness, depression, convulsion, excessive sweating, dizziness and physical dependence.

REJUNURON DN TABLET has high potential to cause addiction and therefore caution should be exercised among patients who already has a history of substance abuse. REJUNURON DN TABLET can cause suicidal ideation in some individuals and therefore appropriate treatment should be considered as soon as the signs emerge.

REJUNURON DN TABLET is not recommended for use in pregnant or breastfeeding women unless advised by the doctor and in male patients who plan to father a child. Consult your doctor before taking REJUNURON DN TABLET.

The most common side effects of taking REJUNURON DN TABLET are dizziness, sleepiness, headache, dry mouth, mood changes, fluid retention and weight gain. Consult your doctor if any of the side effects worsen.

USES OF REJUNURON DN TABLET

  • Treats neuropathic pain in adults

HOW REJUNURON DN TABLET WORKS

REJUNURON DN TABLET effectively alleviates the symptoms of various types of neuropathic pain, where methylcobalamin acts by rejuvenating the damaged neurons by improving the production of myelin (a substance that covers and protects the nerve fibers from damage) and pregabalin acts by interfering with various pain signals travelling through the damaged nerves and the brain, thus leading to a significant pain relief in various neuropathic pain states.

DIRECTIONS FOR USE

Take REJUNURON DN TABLET as advised by your physician. Swallow REJUNURON DN TABLET with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration of REJUNURON DN TABLET for you depending upon your age, body weight and disease condition.

SIDE EFFECTS OF REJUNURON DN TABLET

COMMON

  • dizziness, sleepiness, headache
  • nasopharyngitis (common cold)
  • nausea, vomiting, increased appetite, constipation, diarrhea, flatulence, abdominal distension, dry mouth
  • euphoric mood (feeling excited or pleasurable)
  • confusion, irritability, disorientation
  • insomnia (lack of sleep)
  • decrease in sex drive, erectile dysfunction
  • ataxia (impaired balance or coordination), tremor (shaking)
  • dysarthria (disorder of speech)
  • memory impairment, attention disturbance
  • paresthesia (tingling and numbness in extremities)
  • hypoaesthesia (decreased sense of touch)
  • tiredness
  • blurred vision
  • vertigo (spinning sensation)
  • muscle cramps
  • pain in limbs, joints or back
  • cervical spasm (a sudden, involuntary contraction of a muscle in the neck)
  • peripheral edema
  • fall (accidental injury)
  • weight gain

UNCOMMON

  • abnormally low count of a type of white blood cell (neutrophils).
  • loss of appetite
  • low blood sugar levels
  • hallucination, panic attack, restlessness, agitation, depression
  • elevated mood, aggression, mood swings, depersonalisation, word finding difficulty
  • abnormal dreams, libido increased, anorgasmia, apathy
  • fainting, unresponsiveness (stupor)
  • myoclonus (muscle jerks)
  • loss of consciousness, psychomotor hyperactivity
  • dizziness postural
  • involuntary eye movement
  • cognitive disorder
  • mental impairment
  • hyporeflexia (reduction or absence of normal bodily reflexes)
  • hyperaesthesia (excessive physical sensitivity)
  • burning sensation
  • loss of sensation of taste
  • general discomfort
  • visual disturbance, eye swelling
  • eye pain or strain
  • photopsia (presence of flashes of light or floaters in the vision)
  • dry eye
  • lacrimation increased, eye irritation
  • disorder in loudness perception
  • fast or slow heart rate, congestive heart failure
  • increased or decreased blood pressure
  • hot flushes, flushing, peripheral coldness
  • shortness of breath, bleeding from nose
  • cough, nasal congestion
  • stuffy nose, snoring, nasal dryness
  • gastrooesophageal reflux disease, salivary hypersecretion
  • oral numbness
  • rash popular, urticaria, itching
  • excess sweating
  • joint swelling, muscle or neck pain
  • muscle twitching or stiffness
  • urinary incontinence, painful urination
  • sexual dysfunction, ejaculation delayed
  • pain menstruation or breast pain
  • generalised oedema, face oedema, chest tightness, pain
  • fever, thirst, chills, lack of energy
  • decreased weight

RARE

  • disinhibition (a pattern of antisocial, impulsive, norm-violating tendency)
  • convulsions
  • parosmia (a smell disorder)
  • dysgraphia (trouble in writing)
  • heart problems (such as prolonged QT interval, sinus tachycardia or sinus arrhythmia)
  • pulmonary edema (fluid retention in the lungs) and throat tightness
  • GI tract problems (such as fluid buildup in stomach, pancreatitis, swollen tongue or dysphagia)
  • cold sweats
  • kidney problems (such as renal failure, oliguria and urinary retention)
  • amenorrhea (lack of menstrual periods)
  • breast discharge or enlargement
  • gynecomastia (breast enlargement in males)

Stop taking REJUNURON DN TABLET and contact your doctor immediately if you experience any of the following side effects:

  • severe allergic reactions (such as skin rash, itching, swelling of the face, lips, throat, neck and difficulty in breathing)
  • symptoms of elevated creatine kinase (such as unexplained muscle pain, tenderness or weakness, accompanied by malaise or fever)
  • rhabdomyolysis (severe muscle injury)
  • suicidal ideation or behavior

HOW TO MANAGE SIDE EFFECTS

Bloating

Eat smaller and frequent meals. Eat and drink slowly and exercise regularly. Consult your doctor if the symptom did not improve.

Constipation

Eat fiber rich foods such as fresh fruits, vegetables and cereals and drink plenty of water. Try to exercise more regularly. Consult your doctor if the symptom did not improve on its own.

Diarrhea

Drink lots of fluids such as water or fruit juices to keep yourself hydrated. Avoid taking any medicine on your own for treating diarrhea. Consult your doctor if the symptom did not improve.

Dizziness Or Drowsiness

Try to rest and relax. Get enough sleep. Avoid driving or operating any tools or machines while you are feeling dizzy. Do not consume too much of alcohol, as it can aggravate your dizziness. Consult your doctor if the symptom did not improve.

Headache

Rest and relax. Drink plenty of fluids such as water or electrolytes. Apply a pain-relieving balm on the forehead if required. Do not consume too much of alcohol. Consult your doctor if the symptom did not improve.

Nausea And Vomiting

Try to take REJUNURON DN TABLET with or just after a meal or a snack. Stick to simple meals. Avoid eating rich or spicy food. Consult your doctor if the symptom did not improve.

WARNING & PRECAUTIONS

PREGNANCY
Consult your doctor

There is no proper information on the use of REJUNURON DN TABLET during pregnancy and therefore should be used only if the benefit to the mother clearly outweighs the potential risk to the fetus. Consult your doctor before taking REJUNURON DN TABLET. Women of childbearing potential should use a suitable contraceptive method to avoid pregnancy while taking REJUNURON DN TABLET.

BREASTFEEDING
Monitoring required

REJUNURON DN TABLET is not recommended for use in breastfeeding women unless it is considered clearly necessary. Consult your doctor whether to discontinue breast-feeding or to discontinue therapy with REJUNURON DN TABLET.

DRIVING AND USING MACHINES
Use with Caution

Do not drive or operate any heavy tools or machines if you experience dizziness or sleepiness after taking this medicine. Consult your doctor before taking REJUNURON DN TABLET.

ALCOHOL
Consult your doctor

Avoid consumption of alcohol while taking REJUNURON DN TABLET, as it may cause impairment of motor skills and sedating effects of alcohol. Consult your doctor before taking REJUNURON DN TABLET.

KIDNEY
Use with Caution

REJUNURON DN TABLET should be taken with caution in patients with impaired kidney function. Consult your doctor before taking REJUNURON DN TABLET.

LIVER
Use with Caution

REJUNURON DN TABLET should be taken with caution in patients with liver disease. Consult your doctor before taking REJUNURON DN TABLET.

ALLERGY
Contraindicated

Do not take REJUNURON DN TABLET if you are allergic to Pregabalin, Methylcobalamin or any other ingredients of REJUNURON DN TABLET.

HEART DISEASE
Use with Caution

REJUNURON DN TABLET should be taken with caution in patients with heart disease (such as congestive heart failure). Consult your doctor before taking REJUNURON DN TABLET.

OTHERS

REJUNURON DN TABLET is not recommended for use if you:

  • have Leber’s disease (a hereditary eye disease)
  • have problems in glucose metabolism (Ex. galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption)

Before taking this medicine, inform your physician if you:

  • have history of misuse or substance abuse
  • have folate deficiency
  • have diabetes
  • have epilepsy
  • have or at risk of encephalopathy (a brain disease)

Use in Pediatrics:

REJUNURON DN TABLET is not recommended for use in children and adolescents (aged below 18 years) due to lack of safety data. Consult your child’s doctor for advice.

Use in Geriatrics:

REJUNURON DN TABLET should be used with caution in elderly patients (aged 65 years and above), especially in patients with decreased renal function. Proper dose adjustments and careful monitoring of kidney function are required in such patients. Consult your doctor before taking REJUNURON DN TABLET.

INTERACTIONS

A. Drug-Drug interactions:

Before taking REJUNURON DN TABLET, inform your doctor, if you are taking any of the following medicines:

  • medicines used to reduce blood glucose level (Ex. metformin, pioglitazone, rosiglitazone)
  • anti-spasticity agents (used to reduce muscle stiffness) Ex. dantrolene, baclofen
  • opioid analgesics (Ex. morphine, pethidine) (used to treat severe pain)
  • CNS depressants (Ex. lorazepam) (used to treat anxiety)
  • oral contraceptives (birth control pills) Ex. norethisterone and/or ethinyl estradiol
  • chloramphenicol (an antibiotic used to treat bacterial infections)
  • large doses of folic acid (a vitamin supplement)
  • vitamin C supplements
  • medicines used to control blood cholesterol levels (Ex. cholestyramine or colestipol)
  • colchicine (used to treat gout)
  • para-amino salicylic acid (used to treat tuberculosis)
  • potassium chloride (used to treat low potassium levels)
  • nitrous oxide (an anesthetic)

Overdosage:

If you or anyone else accidentally take too much of REJUNURON DN TABLET, contact your doctor immediately or go to a hospital straight away. Overdosage symptoms of REJUNURON DN TABLET might include sleepiness, confusion, agitation, restlessness, seizures and coma.

SYNOPSIS

Drug :   Pregabalin, Methylcobalamin
Pharmacological Category :   Anticonvulsants, Vitamin B complex
Therapeutic Indication :   Neuropathic pain
Dosage Forms :   Tablet, Capsule, Soft gels

MORE INFORMATION

  • Keep REJUNURON DN TABLET out of reach of children
  • Store REJUNURON DN TABLET at room temperature

FAQs ABOUT REJUNURON DN TABLET

Q: Can REJUNURON DN TABLET affect fertility?

A: Fertility studies in men have shown that there were no effects on sperm motility. However, REJUNURON DN TABLET can be associated with an increased risk of male-mediated teratogenicity (abnormalities in fetus). Men being treated with REJUNURON DN TABLET who plan to father a child should be informed about the potential risk of male-mediated teratogenicity. There are not enough clinical data on the effects of this medicine on female fertility.

Q: Can REJUNURON DN TABLET cause weight gain?

A: Yes, REJUNURON DN TABLET can cause weight gain in some individuals mainly due to the formation of peripheral edema (fluid retention). Weight gain can be more prominent among diabetic patients who are treated with thiazolidinediones (Ex. pioglitazone, rosiglitazone) and so inform your doctor if you have diabetes prior to treatment with REJUNURON DN TABLET as a precaution.

Q: Can REJUNURON DN TABLET decrease libido?

A: Yes, REJUNURON DN TABLET may cause decrease in sex drive (libido) in some individuals, although not everybody gets them. Consult your doctor if this symptom troubles you.

Q: Is REJUNURON DN TABLET addictive?

A: Yes, REJUNURON DN TABLET has high potential to create substance abuse or dependence and therefore caution should be exercised among patients who already has a history of substance abuse. Careful monitoring of symptoms of abuse are required in such patients.

Q: Can I stop taking REJUNURON DN TABLET once my pain is relieved?

A: No. Do not stop taking REJUNURON DN TABLET without consulting your doctor as it could precipitate withdrawal symptoms such as headache, lack of sleep, nausea, pain, diarrhea, flu syndrome, anxiety, nervousness, depression, convulsion, hyperhidrosis and dizziness and dependence. If your condition improves, contact your doctor so that he might reduce the dose appropriately before discontinuation of the therapy with REJUNURON DN TABLET.

REFERENCES

1. KD. Tripathi. Antiepileptic Drugs & Hematinics and Erythropoietin. Essentials of medical pharmacology. Seventh edition. 2013. Page – 420 & 608.

2. Gerald G. Briggs and Roger K. Freeman. A reference guide to fetal and neonatal risk: Drugs in Pregnancy and Lactation. Tenth Edition. 2015. Page – 3223-3225.

3. Yasmin U Dongre and Onkar C Swami. Sustained release pregabalin with methylcobalamin in neuropathic pain: an Indian real-life experience. NCBI; PMC US National Library of Medicine, National Institute of Health. May 2013. [Accessed on 21st October 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674019/

4. Gupta JK and Qureshi Shaiba Sana. Potential Benefits of Methylcobalamin: A Review. Austin Potential benefits of Pharmacology and Therapeutics. 2015. [Accessed on 21st October 2022] https://austinpublishinggroup.com/pharmacology-therapeutics/fulltext/ajpt-v3-id1076.php

5. Ram Prabhoo, Atul Panghate, Raj Pavitra Dewda, Balaji More, Tanay Prabhoo and Rajiv Rana. Efficacy and Tolerability of a Fixed Dose Combination of Methylcobalamin and Pregabalin in the Management of Painful Neuropathy. NCBI; PMC US National Library of Medicine, National Institute of Health. November 2012. [Accessed on 21st October 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503385/

6. Torrent Pharmaceuticals Ltd. Predgeb M OD (Pregabalin Sustained Release and Methylcobalamin Tablets). Torrentian.com. May 2017. [Accessed on 21st October 2022] https://www.torrentian.com/pisheet/Upload/PI_Sheet/1836.pdf

7. Torrent Pharmaceuticals Ltd. Pregalin M (Pregabalin & Methylcobalamin Capsules). Torrentian.com. May 2017. [Accessed on 21st October 2022] https://www.torrentian.com/pisheet/Upload/PI_Sheet/1428.pdf

8. Cipla Ltd. Nova M Capsules (Pregabalin + Methylcobalamin). Ciplamed.com. [Revised in May 2016]. [Accessed on 21st October 2022] https://www.ciplamed.com/content/nova-m-capsules

AUTHOR DETAILS

Written By Dr. R. Dinesh John Rajkumar, Pharm.D
Last updated on 28 Jan 2023 | 11:48 AM(IST)

PRODUCT DETAILS
    Net Qty
    1 N
    Shelf Life
    24
    Item Weight
    17.5 g
    Ingredient
    Methylcobalamin 1500 mcg+Pregabalin 75 mg
    Hsn Code
    30049099
ALTERNATE BRANDS View All
Pregeb M OD 75mg Tablet 15'S
Prescription Neuropathic Pain Rx required
MRP ₹ 287.80
Get this at ₹ 230.24
Get this at 230.24
Cart Total
₹0
Revlin M SR 75mg Tablet 10'S
Prescription Neuropathic Pain Rx required
MRP ₹ 173.92
Get this at ₹ 139.14
Get this at 139.14
Cart Total
₹0
Nervmax SR 75mg Tablet 10'S
Prescription Neuropathic Pain Rx required
MRP ₹ 209.00
Get this at ₹ 167.20
Get this at 167.20
Cart Total
₹0
DISCLAIMER

The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.

Rejunuron DN Tablet 10'S
Rejunuron DN Tablet 10'S Mkt: Fourrts India Laboratories Pvt Ltd
₹ 173.84 MRP ₹ 212.00